Treatment Of Leprosy
p. 88 · Read in the full issue
High Promise in New Drugs
THE Mahaica Hospital in British Guiana has become one of the lead ing leprosy research centres in the British Empire, says G. E. Willock in the December "Colonial Review.” Dr. L. H.
Wharton, the Medical Superintendent, has secured remarkable results from the application of three drugs—Promin, Dia sone and Sulphetrone—and the whole outlook on the dread disease has been changed.
A few patients have been discharged from the hospital as fully cured. The health of most of those under treatment has improved appreciably in the past two years, and Dr. Wharton expects that the number of discharges will increase steadily. Complications such as blindness, deformity, mutilation and chronic ulcers can now be avoided as a result of the new treatments.
Photographs taken of patients at dif ferent stages show the beneficial effects of the three drugs, of which Promin and Diasone are United States products, and Sulphetrone an English drug.
Dr. Wharton has published in medical journals reports on the results he has ob tained from the new drugs, and the re cord of his experiences and his conclu sions on the uses of the new drugs have been publicised in the United States.
Dr. L. G. Poole has returned to Fiji from leave spent in the United Kingdom, and is again in charge of the Tamavua In fectious Diseases Hospital. Dr. P. G.
Griffiths, MC, who has been stationed at Tamavua during Dr. Poole’s absence, has been posted to Makogai, where he will act as Medical Superintendent, Fiji Leprosy Hospital, during the absence on leave of Dr. C. J. Austin, OBE.